Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Early FMT for C.Difficile (NCT02465463)Emory University2015-06-01
Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension (NCT02595541)Assiut University2015-06-01
Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination (NCT02475135)Janssen Sciences Ireland UC2015-06-01
Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects (NCT02456558)ApoPharma2015-06-01
A Study to Assess the Relative Bioavailability of JNJ-42756493 Tablets (NCT02466815)Janssen Research & Development, LLC2015-06-01
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor (NCT02471716)Five Prime Therapeutics, Inc.2015-06-01
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers (NCT02477267)INSYS Therapeutics Inc2015-06-01
Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis (NCT01894373)Chinese PLA General Hospital2015-06-01
Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases (NCT02622841)UMC Utrecht2015-06-01
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment (NCT03160014)Jiangsu HengRui Medicine Co., Ltd.2015-06-01
Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer (NCT02573220)University of Chicago2015-06-01
To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers (NCT02179970)CCTU- Cancer Theme2015-06-01
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer (NCT02465593)PharmaEngine2015-06-01
Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee (NCT02544802)Steminent Biotherapeutics Inc.2015-06-01
Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) (NCT03262636)University of Pennsylvania2015-06-01
Safety/Tolerability and Pharmacokinetic Study of SID142 (NCT02625714)SK Chemicals Co., Ltd.2015-06-01
Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa (NCT02323789)King's College London2015-06-01
PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer (NCT02472275)Barbara Ann Karmanos Cancer Institute2015-06-01
Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet (NCT02400333)AstraZeneca2015-06-01
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye (NCT02420730)Allergan2015-06-01
Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility (NCT02575924)European Hospital2015-06-01
Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2 (NCT02484560)University of Gaziantep2015-06-01
Rivaroxaban in Bariatric Surgery (NCT02438098)Insel Gruppe AG, University Hospital Bern2015-06-01
Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI) (NCT02484482)Chong Kun Dang Pharmaceutical2015-06-01
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers (NCT02482324)AZTherapies, Inc.2015-06-01
Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease (NCT02645305)University of Science Ho Chi Minh City2015-06-01
Safety and Efficacy of Body-mapping Tank Top Equipped With Biofeedback System for Adolescent With Early Scoliosis (NCT02471508)The Hong Kong Polytechnic University2015-06-01
Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF) (NCT02603744)Royan Institute2015-06-01
A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers (NCT02583542)Queen Mary University of London2015-06-01
Study of BLZ-100 in Pediatric Subjects With CNS Tumors (NCT02462629)Blaze Bioscience Inc.2015-06-01
A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy (NCT02473640)Theriva Biologics, Inc.2015-06-01
Phase I Trial: T4 Immunotherapy of Head and Neck Cancer (NCT01818323)King's College London2015-06-01
A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine (NCT02481232)Lanzhou Institute of Biological Products Co., Ltd2015-06-01
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study (NCT02457286)Northwell Health2015-06-01
Testing the Feasibility of Intervening to Optimize Chiropractic Care for Adults With Neck Pain Disorders (NCT02483091)McGill University2015-06-01
Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent (NCT02470559)Barbara Ann Karmanos Cancer Institute2015-06-01
The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation (NCT02393807)Pfizer2015-06-01
Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease (NCT02539784)Assistance Publique - Hôpitaux de Paris2015-06-01
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer (NCT02529579)Changhai Hospital2015-06-01
Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients (NCT02413645)Judit Pich Martínez2015-06-01
A Phase I Study of MLN6907 in Patients With Metastatic Colorectal (NCT02056015)Millennium Pharmaceuticals, Inc.2015-06-01
A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions (NCT02428036)Takara Bio Inc.2015-06-01
Circadian Thermal Sensing to Detect Breast Disease (NCT02511301)Cyrcadia Health2015-06-01
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial (NCT02349009)Prism Pharma Co., Ltd.2015-06-01
Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects (NCT02485769)Pfizer2015-06-01
Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects (NCT02490501)BioArctic AB2015-06-01
An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma (NCT02473939)Vectura Limited2015-06-01
A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen (NCT02478879)Zosano Pharma Corporation2015-06-01
Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy Subjects (NCT02326233)Samsung Bioepis Co., Ltd.2015-06-01
Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report (NCT02955862)National Hospital for Tropical Diseases, Hanoi, Vietnam2015-06-01
Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test (NCT02432027)Prism Pharma Co., Ltd.2015-06-01
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans (NCT02781519)Yale University2015-06-01
Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (NCT03054207)Jules Desmeules2015-06-01
Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers (NCT02485431)PTC Therapeutics2015-06-01
L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients (NCT02808624)Cairo University2015-06-01
the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs (NCT02603003)Shanghai University of Traditional Chinese Medicine2015-06-01
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 (NCT02541370)Chinese PLA General Hospital2015-06-01
Vaccination in Prostate Cancer (VANCE) (NCT02390063)University of Oxford2015-06-01
A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers (NCT02479308)Alkermes, Inc.2015-06-01
Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support (NCT02631174)Children's Hospital Medical Center, Cincinnati2015-06-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus (NCT02445911)Kaneq Bioscience Limited2015-06-01
PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses (NCT02786043)Lee's Pharmaceutical Limited2015-06-01
Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers (NCT02465489)ApoPharma2015-06-01
CAR-T Cell Immunotherapy for HCC Targeting GPC3 (NCT02723942)Fuda Cancer Hospital, Guangzhou2015-06-01
Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers (NCT02466711)Motus Therapeutics, Inc.2015-06-01
Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers (NCT02238834)Foresee Pharmaceuticals Co., Ltd.2015-06-01
Dexmedetomidine for Cesarean Section (NCT02715154)The First Affiliated Hospital with Nanjing Medical University2015-06-01
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer (NCT02450656)The Netherlands Cancer Institute2015-06-01
Drug Interaction Study of Warfarin and MT-3995 (NCT02531568)Tanabe Pharma Corporation2015-06-01
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer (NCT02457910)Vanderbilt-Ingram Cancer Center2015-06-01
Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma (NCT02595242)CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2015-06-01
Belimumab Impacting Transplant Eligibility (NCT02500251)E. Steve Woodle2015-06-01
Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC (NCT02473536)University of Texas Southwestern Medical Center2015-06-01
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus (NCT02472795)Viatris Innovation GmbH2015-06-01
MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) (NCT02410239)Masonic Cancer Center, University of Minnesota2015-06-01
Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas (NCT02454634)National Center for Tumor Diseases, Heidelberg2015-06-01
Assessment of Bone Mineral Density During Pregnancy (NCT02480023)Ain Shams University2015-06-01
Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects (NCT02557789)Nabriva Therapeutics AG2015-06-01
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant (NCT02415764)Center for Social Innovation, Massachusetts2015-06-01
ADME Study in Healthy Male Subjects With TA-8995 (NCT02408055)Xention Ltd2015-06-01
TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects (NCT02772159)Mylan Inc.2015-06-01
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient (NCT03159832)Jiangsu HengRui Medicine Co., Ltd.2015-06-01
Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma (NCT02586285)Eastern Hepatobiliary Surgery Hospital2015-06-01
Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers (NCT02526316)Oryx GmbH & Co. KG2015-06-01
Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation (NCT02342795)Virginia Commonwealth University2015-06-01
Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects (NCT02436577)AstraZeneca2015-06-01
Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia (NCT03005392)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2015-06-01
A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders (NCT02354443)Fate Therapeutics2015-06-01
Feasibility Study of Intraoperative Imaging in Breast Cancer (NCT02438358)Lumicell, Inc.2015-06-01
Dolutegravir Interactions With Artemisinin-based Combination Therapies (NCT02242799)University of Liverpool2015-06-01
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects (NCT02479022)Novo Nordisk A/S2015-06-01
PK Study of Sotagliflozin in Subjects With Hepatic Impairment (NCT02471274)Lexicon Pharmaceuticals2015-06-01
A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food (NCT02482935)Eli Lilly and Company2015-06-01
A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 (NCT02502721)Daewoong Pharmaceutical Co. LTD.2015-06-01
A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese (NCT02786069)Lee's Pharmaceutical Limited2015-06-01
BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM) (NCT02502253)Johns Hopkins University2015-06-01
Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (NCT02401542)Rainier Therapeutics2015-06-01
Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects (NCT02505997)Melinta Therapeutics, Inc.2015-06-01
Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites (NCT02496286)Eastern Regional Medical Center2015-06-01
A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects (NCT02497924)Global Blood Therapeutics2015-06-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.